Avalo Therapeutics, Inc. · NASDAQ:AVTX

Ra Capital Management, L.P. reported a 6.30% stake in Avalo Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Ra Capital Management, L.P. reported a 6.30% stake in Avalo Therapeutics, Inc., 3,483,099 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
6.30%
Shares
3,483,099
Intent
Passive
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
RA Capital Management, L.P.6.30%3,483,099
Peter Kolchinsky6.30%3,483,099
Rajeev Shah6.30%3,483,099
RA Capital Healthcare Fund, L.P.6.30%3,483,099

Source

View original at SEC

Related